Susan Lang, MD, joined the Stanford Gynecologic Oncology fellowship program in July of 2021. She graduated from the University of Virginia School of Medicine during which time she was selected as a member of Alpha Omega Alpha. During medical school her research was focused on the role of Pannexin 1, a large ATP channel protein, in the regulation of myogenic tone of cerebral vasculature. For this work, she was presented with the UVA Summer Research Program award. She additionally acted as a Peer Mentor, engaging in a wide variety of mentoring sessions covering discrete topics from the pre-clinical systems, clinical skills and clerkship material.
Dr. Lang then completed her residency in Obstetrics & Gynecology at Magee-Womens Hospital at the University of Pittsburgh Medical Center. During residency she was a member of the Program Evaluation Committee, Community Provider Council and was the coordinator the Gynecology Morbidity & Mortality Conference. There, she received accolades for professionalism and excellence in resident teaching. She additionally received the Society of Gynecologic Oncology Outstanding Resident in Gynecologic Oncology Award and the American Association of Gynecologic Laparoscopists Recognition of Excellence in Laparoscopic Surgery Award.
During residency, Dr. Lang was involved in several research efforts, her favorite of which was focused on identifying gender-bias in letters of recommendation, a collaborative effort with her Vascular Surgery colleagues. Her academic contributions have been published in Gynecologic Oncology, Current Opinions in Obstetrics & Gynecology, Journal of Surgical Education, JCI Insight, Gynecologic Oncology Reports. Dr. Lang completed her thesis research in the lab of Dr. Oliver Dorigo, focusing on the role of CCL23, a macrophage derived chemokine ligand, in the tumor microenvironment of human ovarian cancer ascites. She has since started working on clinical projects related to peri-operative care and outcomes of her patients.